Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 379

1.

Serum fibroblast growth factor-21 levels are associated with carotid atherosclerosis independent of established cardiovascular risk factors.

Chow WS, Xu A, Woo YC, Tso AW, Cheung SC, Fong CH, Tse HF, Chau MT, Cheung BM, Lam KS.

Arterioscler Thromb Vasc Biol. 2013 Oct;33(10):2454-9. doi: 10.1161/ATVBAHA.113.301599. Epub 2013 Jul 25.

2.

Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes.

Xiao Y, Liu L, Xu A, Zhou P, Long Z, Tu Y, Chen X, Tang W, Huang G, Zhou Z.

Cardiovasc Diabetol. 2015 Jun 6;14:72. doi: 10.1186/s12933-015-0229-9.

3.

Fibroblast Growth Factor-23 and Carotid Artery Intima Media Thickness in Chronic Kidney Disease.

Yilmaz G, Ustundag S, Temizoz O, Sut N, Demir M, Ermis V, Sevinc C, Ustundag A.

Clin Lab. 2015;61(8):1061-70.

PMID:
26427152
4.

Serum fibroblast growth factor 21 levels is associated with lower extremity atherosclerotic disease in Chinese female diabetic patients.

Zhang X, Hu Y, Zeng H, Li L, Zhao J, Zhao J, Liu F, Bao Y, Jia W.

Cardiovasc Diabetol. 2015 Mar 11;14:32. doi: 10.1186/s12933-015-0190-7.

5.

Serum adipocyte fatty acid-binding protein levels were independently associated with carotid atherosclerosis.

Yeung DC, Xu A, Cheung CW, Wat NM, Yau MH, Fong CH, Chau MT, Lam KS.

Arterioscler Thromb Vasc Biol. 2007 Aug;27(8):1796-802. Epub 2007 May 17.

6.

Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease.

Shen Y, Ma X, Zhou J, Pan X, Hao Y, Zhou M, Lu Z, Gao M, Bao Y, Jia W.

Cardiovasc Diabetol. 2013 Aug 28;12:124. doi: 10.1186/1475-2840-12-124.

8.

Contribution of visceral fat accumulation to carotid intima-media thickness in a Chinese population.

Wang Y, Ma X, Zhou M, Zong W, Zhang L, Hao Y, Zhu J, Xiao Y, Li D, Bao Y, Jia W.

Int J Obes (Lond). 2012 Sep;36(9):1203-8. doi: 10.1038/ijo.2011.222. Epub 2011 Nov 29.

9.

Serum fibroblast growth factor 21 was elevated in subjects with type 2 diabetes mellitus and was associated with the presence of carotid artery plaques.

An SY, Lee MS, Yi SA, Ha ES, Han SJ, Kim HJ, Kim DJ, Lee KW.

Diabetes Res Clin Pract. 2012 May;96(2):196-203. doi: 10.1016/j.diabres.2012.01.004. Epub 2012 Jan 30.

PMID:
22293928
10.

Interleukin-2 levels are associated with carotid artery intima-media thickness.

Elkind MS, Rundek T, Sciacca RR, Ramas R, Chen HJ, Boden-Albala B, Rabbani L, Sacco RL.

Atherosclerosis. 2005 May;180(1):181-7. Epub 2005 Jan 8.

PMID:
15823291
11.

Uric acid is an independent risk factor for carotid atherosclerosis in a Japanese elderly population without metabolic syndrome.

Takayama S, Kawamoto R, Kusunoki T, Abe M, Onji M.

Cardiovasc Diabetol. 2012 Jan 10;11:2. doi: 10.1186/1475-2840-11-2.

12.

Microcirculatory damage of common carotid artery wall in obese and non obese subjects.

Ciccone M, Maiorano A, De Pergola G, Minenna A, Giorgino R, Rizzon P.

Clin Hemorheol Microcirc. 1999;21(3-4):365-74.

PMID:
10711772
14.

Epidermal fatty-acid-binding protein: a new circulating biomarker associated with cardio-metabolic risk factors and carotid atherosclerosis.

Yeung DC, Wang Y, Xu A, Cheung SC, Wat NM, Fong DY, Fong CH, Chau MT, Sham PC, Lam KS.

Eur Heart J. 2008 Sep;29(17):2156-63. doi: 10.1093/eurheartj/ehn295. Epub 2008 Jul 4.

PMID:
18603624
15.

Factors associated with carotid intima-media thickness and carotid plaques in type 2 diabetic patients.

Cardoso CR, Marques CE, Leite NC, Salles GF.

J Hypertens. 2012 May;30(5):940-7. doi: 10.1097/HJH.0b013e328352aba6.

PMID:
22495135
16.

Thickened carotid intima media thickness and carotid atherosclerosis among lupus nephritis patients: the role of traditional and lupus-specific factors.

Sazliyana S, Mohd Shahrir MS, Kong NC, Tan HJ, Hamidon BB, Azmi MT.

Int J Rheum Dis. 2011 Aug;14(3):267-75. doi: 10.1111/j.1756-185X.2011.01638.x.

PMID:
21816023
17.

Serum high sensitivity C-reactive protein is associated with carotid intima-media thickness in type 2 diabetes.

Kang ES, Kim HJ, Kim YM, Lee S, Cha BS, Lim SK, Kim HJ, Lee HC.

Diabetes Res Clin Pract. 2004 Dec;66 Suppl 1:S115-20.

PMID:
15563960
18.

The metabolic syndrome and progression of carotid atherosclerosis over 13 years. The Tromsø study.

Herder M, Arntzen KA, Johnsen SH, Mathiesen EB.

Cardiovasc Diabetol. 2012 Jun 27;11:77. doi: 10.1186/1475-2840-11-77. Erratum in: Cardiovasc Diabetol. 2013;12(1):144.

19.

Cardiac troponin I and beta 2 microglobulin as risk factors for early-onset atherosclerosis in patients on haemodialysis.

Zumrutdal A, Sezer S, Demircan S, Seydaoglu G, Ozdemir FN, Haberal M.

Nephrology (Carlton). 2005 Oct;10(5):453-8.

PMID:
16221094
20.

Impact of C-reactive protein on the likelihood of carotid atherosclerosis in Japanese adults.

Kawamoto R, Tomita H, Inoue A, Ohtsuka N, Kamitani A.

J Atheroscler Thromb. 2006 Aug;13(4):175-82.

Supplemental Content

Support Center